MMP inhibition and the development of cerebrovascular atherosclerosis: The road ahead

Stroke

Volumn 33, Issue 12, 2002, Pages 2864-2865

  Napoli, Claudio ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BATIMASTAT; DOXYCYCLINE; GELATINASE A; GELATINASE B; KBR 7785; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; UNCLASSIFIED DRUG; DRUG DERIVATIVE; ENZYME INHIBITOR; GLYCINE; HYDROXAMIC ACID; INTERSTITIAL COLLAGENASE; KB R7785; PHENYLALANINE; THIOPHENE DERIVATIVE;

AGE; ATHEROSCLEROTIC PLAQUE; BRAIN ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; DRUG EFFECT; ENZYME INHIBITION; HUMAN; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NOTE; PRIORITY JOURNAL; ANIMAL; ARTICLE; BRAIN; BRAIN CIRCULATION; CEREBRAL ARTERY DISEASE; DISEASE MODEL; DRUG ANTAGONISM; ENZYMOLOGY; EXTRACELLULAR MATRIX; FEMALE; GENETICS; HEMODYNAMICS; MALE; METABOLISM; TREATMENT OUTCOME; VASCULARIZATION;

ANIMALS; BRAIN; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; EXTRACELLULAR MATRIX; FEMALE; GLYCINE; HEMODYNAMIC PROCESSES; HUMANS; HYDROXAMIC ACIDS; INFARCTION, MIDDLE CEREBRAL ARTERY; INTRACRANIAL ARTERIOSCLEROSIS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MICE; PHENYLALANINE; THIOPHENES; TREATMENT OUTCOME;

EID: 0036901543     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (16)

1. Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: A tail of a frog that became a prince. Nat Rev Mol Cell Biol. 2002;3:207-214.
2. Yong VW, Power C, Forsyth P, Edwards DR. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci. 2001; 2:502-511.
3. Clark AW, Krekoski CA, Bou SS, Chapman KR, Edwards DR. Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Neurosci Lett. 1997;238:53-56.
4. Montaner J, Alvarez-Sabin J, Molina C, Angles A, Abilleira S., Arenillas J, Gonzalez MA, Monasterio J. Matrix metalloproteinase expression after human cardioembolic stroke: Temporal profile and relation to neurological impairment. Stroke. 2001;32:1759-1766.
5. D'Armiento FP, Bianchi A, de Nigris F, Capuzzi DM, D'Armiento MR, Abete P, Crimi G, Palinski W, Condorelli M, Napoli C. Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classical risk factors for atherosclerosis. Stroke. 2001;32:2472-2480.
6. Loftus IM, Naylor AR, Bell PR, Thompson MM, Matrix metalloproteinases and atherosclerotic plaque instability. Br J Surg. 2002;89:680-694.
7. Jiang X, Namura S, Nagata I. Matrix metalloproteinase inhibitor KB-R7785 attenuates brain damage resulting from permanent focal cerebral ischemia in mice. Neurosci Lett. 2001;305:41-44.
8. Lapchak PA, Chapman DF, Zivin JA. Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke. Stroke. 2000;31:3034-3040.
9. Asahi M, Asahi K, Jung JC, del Zoppo GJ, Fini ME, Lo EH. Role for matrix metalloproteinase 9 after focal cerebral ischemia: Effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab. 2000;20:1681-1689.
10. Asahi M, Sumii T, Fini ME, Itohara, S, Lo EH. Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia. Neuroreport. 2001;12:3003-3037.
11. Humbert P, Faivre B, Gibey R, Agache P. Use of anti-collagenase properties of doxycycline in treatment of alpha 1-antitrypsin deficiency panniculitis. Acta Dem Venereol. 1991;71:189-194.
12. Thompson RW, Liao S, Curci JA. Therapeutic potential of tetracycline derivatives to suppress the growth of abdominal aortic aneurysms. Adv Dent Res. 1998;12:159-165.
13. Dursun D, Kim MC, Solomon A, Pflugfelder SC. Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids. Am J Ophthalmol. 2001;132:8-13.
14. Axisa B, Loftus IM, Naylor AR, Goodall S, Jones L, Bell PRF, Thompson MM. A prospective, randomized, double-blind trial investigating the effect of doxycycline on matrix metalloproteinase expression within atherosclerotic carotic plaques. Stroke 2002;33:2858-2865.
15. Napoli C., Paternò R, Faraci FM, Taguchi H, Postiglione A, Heistad DD. Mildly oxidized low-density lipoprotein impairs responses of carotid but not basilar artery in rabbits. Stroke. 1997;28:2266-2272.
16. Napoli C, Witztum JL, de Nigris F, Palumbo G, D'Armiento FP, Palinski W. Intracranial arteries of human fetuses are more resistant to hypercholesterolemia-induced fatty streak formation than extracranial arteries. Circulation. 1999;99:2003-2010.